Forte Biosciences (FBRX) Amortizatization of Intangibles (2016 - 2026)
Forte Biosciences' (FBRX) quarterly Amortizatization of Intangibles came in at $7000.0 in Q1 2026, down 97.08% year-on-year from $240000.0 in Q1 2025, and up 177.78% on a QoQ basis from -$9000.0 in Q4 2025.
Forte Biosciences (FBRX) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 8 years of Amortizatization of Intangibles data on file, last reported at $7000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 97.08% year-over-year to $7000.0 in Q1 2026; TTM through Mar 2026 was $4000.0, a 98.98% decrease from a year earlier, with the FY2025 full-year figure at $237000.0, up 50.0% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $7000.0, up from -$9000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for FBRX reached as high as $240000.0 in Q1 2025 and fell as low as -$9000.0 in Q3 2024.
- Historically, Amortizatization of Intangibles has averaged $50250.0 across 3 years, with a median of $6000.0 in 2024.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 3900.0% in 2025 and fell as far as 105.77% in 2025.
- Year by year, Amortizatization of Intangibles stood at $156000.0 in 2024, then sank by 105.77% to -$9000.0 in 2025, then soared by 177.78% to $7000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $7000.0 in Q1 2026, -$9000.0 in Q4 2025, and $6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Forte Biosciences | 1.37 Bn | 1.31 Bn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2020 | -103,000.00 |
| Mar 31, 2020 | -103,000.00 |
| Mar 31, 2019 | 41,000.00 |
| Mar 31, 2019 | 41,000.00 |